Ypsomed

Update in progress

YPSN.SW (Swiss)

Company RatingNeutral
SectorHealthcare
IndustryMedical Instruments & Supplies

Ypsomed Holding AG and its subsidiaries design, manufacture, and sell injection and infusion systems for safer, simpler self-medication. It operates three segments: Delivery Systems, Diabetes Care, and Others. Delivery Systems offers pen injectors, auto-injectors, wearable injectors, and smart devices under the YDS brand. Diabetes Care sells insulin pumps, infusion sets, needles, glucose monitoring, and related items under mylife. It also provides precision parts and contract manufacturing. Markets through pharma partners, its own network, and distributors. Headquartered in Burgdorf, Switzerland, founded in 1984, with activities in Europe, North America, and globally.

Company score

Sentiment: 0.30; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: -0.06; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.22; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.09; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.06; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.18; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive